跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15 条关于
“R327G”
全部
15
临床试验
0
药物
0
机构
0
资讯
15
去年
Recce Pharmaceuticals' Topical Gel R327G Reaches Midpoint in Phase II Trial
去年
Recce Pharmaceuticals' R327G Shows Promise in Phase II ABSSSI Trial
去年
Recce Pharmaceuticals' R327G Shows Promise in Phase II ABSSSI Trial
去年
Recce Pharmaceuticals' Phase II Trial of R327G for ABSSSI Reaches Halfway Enrollment
去年
Recce Pharmaceuticals' R327G Shows 93% Efficacy in Phase II Trial for Bacterial Skin Infections
去年
Recce Pharmaceuticals' RECCE 327 Topical Gel Receives Indonesian Approval for Phase 3 Diabetic Foot Infection Trial
去年
Recce Pharmaceuticals Anticipates Key Clinical Trial Milestones for R327 Topical Gel
去年
Recce Pharmaceuticals' Phase II Trial of RECCE® 327 Topical Gel Nears Completion with Positive Interim Results
去年
Recce Pharmaceuticals' RECCE 327 Gel Shows Promise in Phase II ABSSSI Trial
去年
Recce Pharmaceuticals Receives Ethics Approval in Indonesia for Phase 3 Diabetic Foot Infection Trial
第 1 页,共 2 页
上一页
下一页